Author:
Seo Youngsil,Jun Hye-Ryeong,Lee Joungmin,Park Hyunjoon,Kim Minjae,Lee Youngsoo,Kwon Myung-Hee
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference20 articles.
1. Rekvig, O. P. (2015). Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: Critical remarks. Clinical and Experimental Immunology, 179, 5–10.
2. Williamson, R. A., Burgoon, M. P., Owens, G. P., Ghausi, O., Leclerc, E., Firme, L., et al. (2001). Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 98, 1793–1798.
3. Parkhomenko, T. A., Legostaeva, G. A., Doronin, B. M., Buneva, V. N., & Nevinsky, G. A. (2010). IgGs containing light chains of the lambda and kappa type and of all subclasses (IgG1–IgG4) from sera of patients with multiple sclerosis hydrolyze DNA. Journal of Molecular Recognition, 23, 486–494.
4. Parkhomenko, T. A., Doronin, V. B., Castellazzi, M., Padroni, M., Pastore, M., Buneva, V. N., et al. (2014). Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis. PLoS ONE, 9, e93001.
5. Pavlovic, M., Kats, A., Cavallo, M., Chen, R., Hartmann, J. X., & Shoenfeld, Y. (2011). Pathogenic and epiphenomenal anti-DNA antibodies in SLE. Autoimmune Diseases, 2011, 462841.